Safety and Cost-Effectiveness of Outpatient Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
Authors:
- Imran AhmadIAImran Ahmad
- Sandra CohenSCSandra Cohen
- Jean RoyJRJean Roy
- Silvy LachanceSilvy Lachance
- Miguel ChagnonMCMiguel Chagnon
- Richard LeBlancRLRichard LeBlanc
- Lea BernardLBLea Bernard
- Lambert BusqueLBLambert Busque
- Denis Claude RoyDRDenis Claude Roy
- Guy SauvageauGSGuy Sauvageau
- Thomas L. KissTKThomas L. Kiss
Open Access
- 1 April 2013
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 19 (4) , 547-551
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009Bone Marrow Transplantation, 2009
- Autologous Stem Cell Transplant in 716 Patients With Multiple Myeloma: Low Treatment-Related Mortality, Feasibility of Outpatient Transplant, and Effect of a Multidisciplinary Quality InitiativeMayo Clinic Proceedings, 2008
- Outpatient high‐dose melphalan in multiple myeloma patientsTransfusion, 2006
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost studyBone Marrow Transplantation, 2005
- Outpatient-based peripheral blood stem cell transplantation for patients with multiple myelomaThe Hematology Journal, 2004
- Cost analysis of autologous peripheral blood stem cell transplantation for multiple myelomaClinical and Laboratory Haematology, 2003
- Feasibility and cost-effectiveness of outpatient autotransplants in multiple myelomaBone Marrow Transplantation, 1997
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- High-dose melphalan with autologous bone marrow transplantation for multiple myelomaBlood, 1986